Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Decibel Therapeutics (DBTX)

Decibel Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DBTX
DateTimeSourceHeadlineSymbolCompany
10/10/202321:56Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:DBTXDecibel Therapeutics Inc
25/09/202321:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202321:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202321:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202321:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202321:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202314:09Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202314:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202314:03Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202314:00Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202313:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBTXDecibel Therapeutics Inc
25/09/202313:53Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DBTXDecibel Therapeutics Inc
12/09/202321:12Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DBTXDecibel Therapeutics Inc
08/09/202321:23Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:DBTXDecibel Therapeutics Inc
25/08/202314:17Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:DBTXDecibel Therapeutics Inc
25/08/202312:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBTXDecibel Therapeutics Inc
11/08/202312:45GlobeNewswire Inc.Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate UpdateNASDAQ:DBTXDecibel Therapeutics Inc
11/08/202312:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DBTXDecibel Therapeutics Inc
09/08/202321:55Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:DBTXDecibel Therapeutics Inc
09/08/202314:34Dow Jones NewsDecibel Therapeutics Shares Surge on Regeneron AcquisitionNASDAQ:DBTXDecibel Therapeutics Inc
09/08/202313:14Dow Jones NewsRegeneron To Acquire Decibel TherapeuticsNASDAQ:DBTXDecibel Therapeutics Inc
09/08/202313:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBTXDecibel Therapeutics Inc
09/08/202312:30GlobeNewswire Inc.Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss ProgramsNASDAQ:DBTXDecibel Therapeutics Inc
14/06/202321:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DBTXDecibel Therapeutics Inc
14/06/202321:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DBTXDecibel Therapeutics Inc
14/06/202321:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DBTXDecibel Therapeutics Inc
13/06/202321:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DBTXDecibel Therapeutics Inc
02/06/202312:00GlobeNewswire Inc.Decibel Therapeutics to Participate in the Upcoming Jefferies Healthcare ConferenceNASDAQ:DBTXDecibel Therapeutics Inc
01/06/202321:30GlobeNewswire Inc.Decibel Therapeutics to Present DB-020 Phase 1b Clinical Trial Data at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingNASDAQ:DBTXDecibel Therapeutics Inc
17/05/202321:30GlobeNewswire Inc.Decibel Therapeutics to Participate in the Upcoming Barclays 2023 Gene Editing and Gene Therapy SummitNASDAQ:DBTXDecibel Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:DBTX

Your Recent History

Delayed Upgrade Clock